16:35 EDT Metagenomi (MGX) sees cash, equivalents supporting operations into 2027
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MGX:
- Metagenomi price target lowered to $7 from $14 at H.C. Wainwright
- Biotech stocks slide as Marks resignation seen being negative for sector
- BMO says Peter Marks resignation ‘significant negative’ for biotech
- Metagenomi Faces Legal Battle Over Alleged Misleading Statements in Moderna Collaboration
- Metagenomi, Inc. Reports 2024 Financial Results and Pipeline Progress